Publications by authors named "Gregory Ravizzini"

Claim this Profile
W
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer.
Andrew M Fang, Brian F Chapin, Charles W Shi, Jia Sun, Aliya Qayyum, Gregory C Ravizzini

Prostate Cancer Prostatic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Three Therapeutic Radiopharmaceutical Infusion Methods for Single and Multivial Applications.
Freddy Gonzalez, Gregory C Ravizzini, Gera Santiago, Beth Chasen, Akram Hussein

J Nucl Med Technol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron Emission Tomography Radiotracers for Identification of Site of Recurrence in Prostate Cancer After Primary Treatment Failure.
Ryan Bitar, Pablo Zurita, Lucia Martiniova, Amado J Zurita, Gregory C Ravizzini

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous radiofrequency ablation of an actively bleeding renal angiomyolipoma.
Pedro Ivo Ravizzini, Henrique Augusto Lino, Gregory Ravizzini, Luís Gustavo Morato de Toledo

Einstein (Sao Paulo)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Quantitative Parameters of F-FDG PET/CT in Patients with Liposarcoma.
Lucia Martiniova, Serageldin Kamel, Kalevi Kairemo, Robert Benjamin, Neeta Somaiah, Gregory Ravizzini

Diagnostics (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interreader and Intrareader Reproducibility of F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies.
Phillip H Kuo, Giuseppe Esposito, Gary A Ulaner, Don Yoo, Katherine Zukotynski, Gregory C Ravizzini

J Nucl Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the effectiveness of MRI, F-fluciclovine PET, SUV, and PSA in detecting local recurrence of prostate cancer after prostatectomy.
Mayur K Virarkar, Stephen K Gruschkus, Gregory C Ravizzini, Sai Swarupa R Vulasala, Sanaz Javadi

Pol J Radiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI and PSMA PET/CT of Biochemical Recurrence of Prostate Cancer.
Muhammad O Awiwi, Migena Gjoni, Raghunandan Vikram, Emre Altinmakas, Hakan Dogan, Gregory Ravizzini

Radiographics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski

J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry of a Novel Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human Primates.
Gregory Ravizzini, William Erwin, Louis De Palatis, Lucia Martiniova, Vivek Subbiah

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy.
Mohammed Abusalem, Lucia Martiniova, Sarita Soebianto, Louis DePalatis, Gregory Ravizzini

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).
Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski

J Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski

J Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Radiolabeled Monoclonal Antibodies in Cancer Imaging and ADC Treatment.
Lucia Martiniova, Rafal J Zielinski, Mai Lin, Louis DePalatis, Gregory C Ravizzini

Cancer J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.
Franklin C Wong, Lucia Martiniova, Avantika Masrani, Gregory C Ravizzini

Clin Nucl Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT.
Devaki Shilpa Sudha Surasi, Lilie Lin, Gregory Ravizzini, Franklin Wong

Clin Nucl Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib.
Ajalaya Teyateeti, Armeen Mahvash, James Long, Mohamed Abdelsalam, Rony Avritscher, Gregory Ravizzini

World J Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibody based radiopharmaceuticals for imaging and therapy.
Mai Lin, Vincenzo Paolillo, Dao B Le, Homer Macapinlac, Gregory C Ravizzini

Curr Probl Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastases.
Kalevi Kairemo, Jason Roszik, Pete Anderson, Gregory Ravizzini, Arvind Rao

Curr Probl Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
Ali Baiomy, Dawid Schellingerhout, Brian F Chapin, Jeffrey S Weinberg, Shaan M Raza, Gregory Ravizzini

Nucl Med Commun· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT.
Ali Baiomy, Lucia Martiniova, Eleni Efstathiou, David M Schuster, Gregory Ravizzini

Clin Nucl Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.
Ali Baiomy, Corey T Jensen, John F Ward, Beth A Chasen, Gregory C Ravizzini

Clin Nucl Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of F-fluciclovine PET/CT in prostate cancer patients with rising PSA level ≤ 0.5 ng/ml after multiple treatment failures.
Ajalaya Teyateeti, Achiraya Teyateeti, Gregory C Ravizzini, Guofan Xu, Chad Tang

Am J Nucl Med Mol Imaging· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-Fluciclovine Uptake in a Ureterocele.
Ryan Bitar, Janio Szklaruk, Lucia Martiniova, Amado J Zurita, Lisly J Chery, Gregory Ravizzini

Clin Nucl Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of P-cadherin-targeted Radioimmunotherapy with Y-FF-21101 Monoclonal Antibody in Solid Tumors.
Vivek Subbiah, William Erwin, Osama Mawlawi, Asa McCoy, David Wages, Gregory Ravizzini

Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis